T
RDY icon

Tahithromos’s Dr. Reddy's Laboratories RDY Stock Holding History

Tahithromos’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-250,000
Closed -$3.2M – 25
2015
Q3 		$3.2M Hold
250,000
– – 2.97% 9
2015
Q2 		$2.77M Hold
250,000
– – 3.8% 9
2015
Q1 		$2.85M Hold
250,000
– – 1.32% 25
2014
Q4 		$2.52M Hold
250,000
– – 1.21% 20
2014
Q3 		$2.63M Hold
250,000
– – 0.68% 33
2014
Q2 		$2.16M Hold
250,000
– – 0.51% 34
2014
Q1 		$2.19M Buy
+250,000
New +$2.17M 0.53% 30

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tahithromos's RDY Position: Q4 2015 in Review

Tahithromos sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 250,000 shares — an estimated $3.2M sold.

Tahithromos first reported a position in RDY in Q1 2014 and held it in 7 quarters. The position peaked at $3.2M in Q3 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • Tahithromos reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • Tahithromos sold 250,000 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $3.2M.
  • Tahithromos first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 7 quarters.
  • Tahithromos's Dr. Reddy's Laboratories position peaked at $3.2M in Q3 2015.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Tahithromos's 13F filing for Q4 2015, filed 3 Feb 2016.